Evidence map›Paper›PMID 40099517›Full record

ArticleTissue barriers2025

VE-cadherin RGD motifs are dispensable for cell-cell junctions, endothelial barrier function and monocyte extravasation.

Rianne M Schoon, Werner J van der Meer, Anne-Marieke D van Stalborch, Jaap D van Buul, Stephan Huveneers

Abstract read
In one paragraph

Article in Tissue barriers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rianne M SchoonAmsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Werner J van der MeerAmsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Anne-Marieke D van StalborchAmsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Jaap D van BuulAmsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Stephan HuveneersAmsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-1091-475X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

VE-cadherin is a key transmembrane protein involved in endothelial cell-cell junctions, playing a crucial role in maintaining vascular integrity and regulating selective leukocyte extravasation into inflamed tissue. The extracellular domain of human VE-cadherin contains two arginine-glycine-aspartate (RGD) motifs, which are known integrin-binding sites within extracellular matrix proteins, particularly for integrins of the β1, β3, and β5 families. In this study, we examined the functional relevance of these RGD motifs by generating VE-cadherin variants in which the RGD sequences were mutated to nonfunctional RGE. Immunofluorescence analysis showed that the VE-cadherin [D238E], VE-cadherin [D301E], and double-mutant VE-cadherin [D238/301E] variants formed stable endothelial cell-cell junctions that were comparable to junctions based on wild-type VE-cadherin. Additionally, electric cell-substrate impedance sensing (ECIS) confirmed that endothelial cells expressing each VE-cadherin RGD>RGE variant maintained efficient barrier function capacity. Moreover, monocyte transmigration assays demonstrated that the RGD>RGE mutations did not affect monocyte-endothelial interactions during transmigration. In summary, our findings indicate that the VE-cadherin RGD motifs are not essential for endothelial junction formation or monocyte transmigration.

Indexed as

Antigens, CDCadherinsEndothelial CellsIntercellular JunctionsMonocytesOligopeptidesAmino Acid MotifsCadherin 5HumansAntigens, CDarginyl-glycyl-aspartic acidCadherin 5CadherinsOligopeptidesAdherens junctionsbarrier integrityintegrinsleukocyte extravasationRGD motifVE-cadherin

Identifiers

PMID40099517
PMCPMC12667659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.